ArticleFrontiers in pharmacology2022

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease

Sa Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.